ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $86,000 | -82.2% | 18,265 | -83.8% | 0.00% | -83.3% |
| Q3 2019 | $483,000 | +392.9% | 112,765 | +568.6% | 0.02% | +300.0% |
| Q2 2019 | $98,000 | -75.9% | 16,865 | -74.5% | 0.01% | -71.4% |
| Q3 2017 | $406,000 | -84.1% | 66,147 | -83.9% | 0.02% | -84.6% |
| Q2 2017 | $2,559,000 | +266.1% | 411,547 | +273.0% | 0.14% | +325.0% |
| Q1 2017 | $699,000 | -11.7% | 110,339 | -23.5% | 0.03% | -20.0% |
| Q2 2016 | $792,000 | -54.3% | 144,307 | -38.2% | 0.04% | -48.1% |
| Q1 2016 | $1,732,000 | -75.3% | 233,464 | -64.1% | 0.08% | -68.0% |
| Q1 2015 | $7,000,000 | +2187.6% | 650,027 | +460.8% | 0.24% | +1621.4% |
| Q3 2014 | $306,000 | -32.5% | 115,919 | +3.0% | 0.01% | -41.7% |
| Q2 2014 | $453,000 | +8.1% | 112,519 | +22.8% | 0.02% | +9.1% |
| Q1 2014 | $419,000 | – | 91,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |